<?xml version="1.0" encoding="UTF-8"?>
<p id="p0080">Although SARS-CoV-2 emerged only very recently, several inhibitors have already been identified and successfully co-crystallised with M
 <sup>pro</sup> (
 <xref rid="f0030" ref-type="fig">Fig. 6</xref> ).
 <xref rid="b0295" ref-type="bibr">59</xref>, 
 <xref rid="b0395" ref-type="bibr">79</xref>, 
 <xref rid="b0455" ref-type="bibr">91</xref> They are often derived from previous campaigns which targeted the main proteases of SARS-CoV or MERS-CoV and contain cysteine-reactive warheads (
 <xref rid="f0030" ref-type="fig">Fig. 6</xref>).
</p>
